Skip to main content
. 2013 Nov 4;6(1):19. doi: 10.1186/1939-4551-6-19

Table 2.

Responses to selected survey questions

Question Latin America (n=2,169) Argentina (n=436) Brazil (n=400) Mexico (n=532) Puerto Rico (n=401) Venezuela (n=400)
Daytime symptom frequency, %
 
 
 
 
 
 
  Every day/most days
24
35
27
12
34
18
  1-2 days/week
22
25
20
20
15
29
  1-2 times/month
11
8
10
18
7
11
  No daytime symptoms
44
32
44
50
43
42
Nighttime symptom frequency, %
 
 
 
 
 
 
  Every night/most nights
20
28
24
9
26
14
  1-2 nights/week
16
20
16
16
15
18
  1-2 times/month
10
8
11
12
5
10
  No nighttime symptoms
53
45
50
62
53
58
Subjects with episodes in the past 12 months with asthma symptoms more frequent or more severe than normal, %
47
57
46
42
61
48
Median number of episodes
2
3
2
3
3
3
Subjects who agreed with the following statements, %
 
 
 
 
 
 
  Long-term control medicines should be taken every day
41
61
41
48
61
26
  Long-term control medicines are not necessary when asthma symptoms are not experienced regularly
65
55
67
54
59
72
  Quick relief medications can be used every day if needed
61
68
58
56
84
71
Subjects reporting ≥1 week of interrupted asthma controller medicine use, %
 
 
 
 
 
 
  <2 weeks
26
32
26
29
15
21
  3-4 weeks
9
10
8
14
9
10
  ≥1 month
61
49
52
52
71
65
GINA 2009 asthma control levels
 
 
 
 
 
 
  Well controlled, %
8
5
9
9
8
3
  Partly controlled, %
57
48
57
56
59
65
  Uncontrolled, % 35 57 34 35 33 32

GINA=Global initiative for asthma.